Quality of Life in Gestational Trophoblastic Neoplasia Patients after Treatment in Thailand

  • Published : 2015.01.22


Background: Gestational trophoblastic neoplasia (GTN) is a malignant disease which occurs in women of reproductive age. Treatment of GTN has an excellent outcome and further pregnancies can be expected. However, data concerning quality of life in these cancer survivor patients are limited. This study aimed to assess quality of life in women who were diagnosed with GTN and remission after treatment, and to determine factors that may affect quality of life status. Materials and Methods: This cross sectional study was conducted from July 2013 to May 2014 in the Gestational Trophoblastic Disease Clinic, King Chulalongkorn Memorial Hospital, Bangkok, Thailand. Patients who were diagnosed GTN and complete remission were recruited. Data collection was accomplished by interview with two sets of questionnaires, one general covering demographic data and the other focusing on quality of life, the fourth version of Functional Assessment of Cancer Therapy (FACT-G). Descriptive statistics were used to determine general data and quality of life scores. Students t-test and one way ANOVA were used to compare between categorical and continuous data. Results: Forty four patients were enrolled in this study. The overall mean quality of life score (FACT-G) was 98.2. The overall FACT-G score was not significantly correlated with age, education level, stage of disease, treatment modalities, and time interval from remission to enrollment. However, patients who needed further fertility showed significant lower FACT-G scores in the emotional well-being domain (p=0.02). Conclusions: Overall quality of life scores in post-treatment gestational trophoblastic neoplasia patients are in the mild impairment range. Patients who desire fertility suffer lower quality of life in the emotional well-being domain.


  1. Cagayan MS, Llarena RT (2010). Quality of life of gestational trophoblastic neoplasia survivors: a study of patients at the Philippine general hospital trophoblastic disease section. J Reprod Med, 55, 321-6.
  2. Fisch MJ, Titzer ML, Kristeller JL, et al (2003). Assessment of quality of life in outpatients with advanced cancer: the accuracy of clinician estimations and the relevance of spiritual well-being-a hoosier oncology group study. J Clin Oncol, 21, 2754-9.
  3. Kim JH, Park DC, Bae SN, et al (1998). Subsequent reproductive experience after treatment for gestational trophoblastic disease. Gynecol Oncol, 71, 108-12.
  4. Lurain JR (2011). Gestational trophoblastic disease II: classification and management of gestational trophoblastic neoplasia. Am J Obstet Gynecol, 204, 11-8.
  5. Manopunya M, Suprasert P (2012). Resistant gestational trophoblastic neoplasia patients treated with 5-fluorouracil plus actinomycin D. Asian Pac J Cancer Prev, 13, 387-90.
  6. Ng TY, Wong LC (2003). Diagnosis and management of gestational trophoblastic neoplasia. Best Pract Res Clin Obstet Gynaecol, 17, 893-903.
  7. Ngan HY (2004). The practicability of FIGO 2000 staging for gestational trophoblastic neoplasia. Int J Gynecol Cancer, 14, 202-5.
  8. Ozalp SS, Oge T (2013). Gestational trophoblastic diseases in Turkey. J Reprod Med, 58, 67-71.
  9. Ozalp SS, Telli E, Oge T, et al (2014). Multicenter analysis of gestational trophoblastic neoplasia in Turkey. Asian Pac J Cancer Prev, 15, 3625-8.
  10. Palmer JR (1994). Advances in the epidemiology of gestational trophoblastic disease. J Reprod Med, 39, 155-62.
  11. Petersen RW, Ung K, Holland C, et al (2005). The impact of molar pregnancy on psychological symptomatology, sexual function, and quality of life. Gynecol Oncol, 97, 535-42.
  12. Pinar G, Okdem S, Dogan N, et al (2012). The effects of hysterectomy on body image, self-esteem, and marital adjustment in Turkish women with gynecologic cancer. Clin J Oncol Nurs, 16, 99-104.
  13. Pongsaranantakul S, Kietpeerakool C (2009). Hysterectomy in gestational trophoblastic neoplasia: Chiang Mai University Hospital's experience. Asian Pac J Cancer Prev, 10, 311-4.
  14. Ratanatharathorn V, Sirilerttrakul S, Jirajarus M, et al (2001). Quality of life, functional assessment of cancer therapygeneral. J Med Assoc Thai, 84, 1430-42.
  15. Seckl MJ, Fisher RA, Salerno G, et al (2000). Choriocarcinoma and partial hydatidiform moles. Lancet, 356, 36-9.
  16. Seckl MJ, Sebire NJ, Berkowitz RS (2010). Gestational trophoblastic disease. Lancet, 376, 717-29.
  17. Srisuttayasathien M, Khemapech N (2013). Quality of life in ovarian cancer patients choosing to receive salvage chemotherapy or palliative treatment. Asian Pac J Cancer Prev, 14, 7669-74.
  18. Stafford L, McNally OM, Gibson P, et al (2011). Long-term psychological morbidity, sexual functioning, and relationship outcomes in women with gestational trophoblastic disease. Int J Gynecol Cancer, 21, 1256-63.
  19. Uberti EM, Fajardo Mdo C, Ferreira SV, et al (2009). Reproductive outcome after discharge of patients with high-risk hydatidiform mole with or without use of one bolus dose of actinomycin D, as prophylactic chemotherapy, during the uterine evacuation of molar pregnancy. Gynecol Oncol, 115, 476-81.
  20. Wenzel L, Berkowitz RS, Newlands E, et al (2002). Quality of life after gestational trophoblastic disease. J Reprod Med, 47, 387-94.
  21. Wilailak S, Lertkhachonsuk AA, Lohacharoenvanich N, et al (2011). Quality of life in gynecologic cancer survivors compared to healthy check-up women. J Gynecol Oncol, 22, 103-9.